Cookies show us what works. Privacy
Cookies show us what works. Privacy
31 funds hold it · Insiders net selling
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Period ending
Sep 30, 2026
Earnings per share
$0.65 expected
Estimates as of Nov 10, 2026
EPS expected
$0.89 to $0.99
Revenue expected
5 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 4, 2026 | $0.68est. $0.65 | +5.17%beat | $768.5MSEC filing | +9.7%from $700.8M |
| Jun 30, 2026Reported Aug 5, 2026 | $0.69est. $0.67 | +3.56%beat | $762.5MSEC filing | +11.2%from $685.9M |
| Mar 31, 2026Reported May 6, 2026 | $0.61est. $0.47 | +30.23%beat | $712.2MSEC filing | +12.0%from $635.9M |
| Dec 31, 2025Reported Feb 4, 2026 | $0.89est. $0.88 | +1.06%beat | $802.3MAlpha Vantage | +10.4%from $726.6M |
| Sep 30, 2025Reported Nov 5, 2025 | $0.59est. $0.54 | +9.26%beat | $700.8MSEC filing | +9.5%from $640.2M |
| Jun 30, 2025Reported Aug 6, 2025 | $0.58est. $0.51 | +13.73%beat | $685.9MSEC filing | +9.7%from $625.1M |
| Mar 31, 2025Reported May 7, 2025 | $0.41est. $0.34 | +20.59%beat | $635.9MSEC filing | +7.1%from $594.0M |
| Dec 31, 2024Reported Feb 5, 2025 | $0.80est. $0.75 | +6.67%beat | $726.6MAlpha Vantage | +7.5%from $676.2M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $802.3M | $712.2M | $762.5M | $768.5M |
| Cost of what it sold | $367.2M | $383.5M | $367.8M | $373.5M |
| Gross profit | $435.1M | $328.7M | $394.6M | $395.1M |
| What it spent | ||||
| Research and development | $66.9M | $70.2M | $70.3M | $72.3M |
| Sales and admin | $89.0M | $86.5M | $85.8M | $86.4M |
| Other operating costs | $113.3M | $75.9M | $120.5M | $114.5M |
| Total operating expenses | $269.1M | $232.5M | $276.6M | $273.1M |
| What was left | ||||
| Operating profit | $166.0M | $96.2M | $118.0M | $121.9M |
| Interest on debt | $290.0K | — | — | — |
| Profit before tax | $167.6M | $98.3M | $125.2M | $129.9M |
| Tax | $37.8M | $10.4M | $31.8M | $32.5M |
| Net profit | $129.8M | $87.9M | $93.4M | $97.4M |
| EBITDA | $191.8M | $121.6M | $149.0M | $151.0M |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is neutral
On the Eve of Anthropic's IPO, a Long-Form New York Times Profile Reveals Amodei: Cancer at 31, a Break With Altman, and Four Co-Founders From One Shared House
NeutralNov 9Form 4 NEW YORK TIMES CO: Margot Golden (Director) For: 22 October
NeutralOct 27New York Times (NYT) director Subramanian receives 38 stock units; reported holdings total 11,973 shares.
NeutralOct 27New York Times (NYT) director Rogers acquires 111 dividend-linked stock units.
NeutralOct 27